Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.
about
Induction of C/EBP homologous protein-mediated apoptosis and autophagy by licochalcone A in non-small cell lung cancer cellsMetastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines.Metastatic pheochromocytoma and paraganglioma.PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.Clinical characteristics and surgical outcomes of primary spinal paragangliomas.Progress in Endocrine Neoplasia.Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior.Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model.New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma.Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier.Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer.Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress.Endoplasmic reticulum stress-mediated autophagy protects against β,β-dimethylacrylshikonin-induced apoptosis in lung adenocarcinoma cells.
P2860
Q36906811-CB88C5AF-A86F-4354-9F3B-208920F087B7Q37399102-8460A861-DC43-496E-85F9-E0C56B52B185Q38548784-8A4D4644-914E-4123-BDEB-618FB6E6591FQ38892571-CEE65D53-12A5-4CE6-9E0F-8FBBD3D91328Q39008690-AFB34F46-F592-4644-B544-20A8EEDDDF66Q41346267-25F6D36D-A4F6-4CDB-B3EF-F19AE8D244FCQ42285779-BE23BD43-B5DC-4ED5-82D9-9E3D54CB6329Q47181092-7AA4A32B-98D6-432E-AA56-58B64A60BA2AQ47557128-2FA52BDD-DDA0-475B-AA96-FE486D056986Q47934716-CDBDFAD5-AF10-402A-BD51-1633F10F0733Q52330375-74359E9A-744D-4DBD-898A-66DE67D35114Q53762742-74E42898-37F8-4417-AB5C-291C3D652B7EQ54676019-3C91452C-1843-4985-A12E-00BD0CE2E50EQ54976476-2EF45FED-0006-488A-B2B7-B21A08097D9CQ54987382-329D299F-0ABA-4950-BFA7-699ACD21612AQ55220293-A1477EAE-495C-4360-9FB2-AB3164BA0C0A
P2860
Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chemotherapy with cyclophospha ...... atic review and meta-analysis.
@en
type
label
Chemotherapy with cyclophospha ...... atic review and meta-analysis.
@en
prefLabel
Chemotherapy with cyclophospha ...... atic review and meta-analysis.
@en
P2093
P356
P1476
Chemotherapy with cyclophospha ...... matic review and meta-analysis
@en
P2093
E P M Corssmit
L T van Hulsteijn
N D Niemeijer
P304
P356
10.1111/CEN.12542
P577
2014-07-30T00:00:00Z